日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Generic design principles for antibody-based tumour necrosis factor (TNF) receptor 2 (TNFR2) agonists with FcγR-independent agonism

具有 FcγR 非依赖性激动作用的抗体型肿瘤坏死因子 (TNF) 受体 2 (TNFR2) 激动剂的通用设计原则

Mohamed A Anany, Stefanie Haack, Isabell Lang, Julia Dahlhoff, Juan Gamboa Vargas, Tim Steinfatt, Lea Päckert, Daniela Weisenberger, Olena Zaitseva, Juliane Medler, Kirstin Kucka, Tengyu Zhang, Tom Van Belle, Luc van Rompaey, Andreas Beilhack, Harald Wajant

Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression

瞬时调节性 T 细胞靶向触发多发性骨髓瘤的免疫控制并阻止疾病进展

Julia Dahlhoff, Hannah Manz, Tim Steinfatt, Julia Delgado-Tascon, Elena Seebacher, Theresa Schneider, Amy Wilnit, Zeinab Mokhtari, Paula Tabares, David Böckle, Leo Rasche, K Martin Kortüm, Manfred B Lutz, Hermann Einsele, Andreas Brandl, Andreas Beilhack

A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity

具有增强体内活性的 TNFR2 特异性 TNF 融合蛋白

Juan Gamboa Vargas, Jennifer Wagner, Haroon Shaikh, Isabell Lang, Juliane Medler, Mohamed Anany, Tim Steinfatt, Josefina Peña Mosca, Stephanie Haack, Julia Dahlhoff, Maike Büttner-Herold, Carolin Graf, Estibaliz Arellano Viera, Hermann Einsele, Harald Wajant, Andreas Beilhack

TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity

具有靶向控制 FcγR 非依赖性激动活性的 TNFRSF 受体特异性抗体融合蛋白

Juliane Medler, Johannes Nelke, Daniela Weisenberger, Tim Steinfatt, Moritz Rothaug, Susanne Berr, Thomas Hünig, Andreas Beilhack, Harald Wajant